Argon Laser Peripheral Iridoplasty in the Management of Phacomorphic Glaucoma
- 1 July 2005
- journal article
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 36 (4), 286-291
- https://doi.org/10.3928/1542-8877-20050701-06
Abstract
Ophthalmic Surgery, Lasers and Imaging Retina | * BACKGROUND AND OBJECTIVE: To document the efficacy and safety of argon laser peripheral iridoplasty (ALPI) as a temporizing measure in the treatment of phacomorphic glaucoma and to evaluate the mid-term visual outcomes.* PATIENTS AND METHODS: The clinical records of all patients with phacomorphic glaucoma treated with ALPI from December 1999 to December 2002 were retrospectively reviewed. TheThis publication has 13 references indexed in Scilit:
- Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma A prospective, randomized, controlled trialOphthalmology, 2002
- Limited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: A preliminary studyEye, 1999
- Neodymium:YAG Laser Iridotomy An, the Initial Management of Phacomorphic GlaucomaOphthalmology, 1992
- Laser and Unsutured Sclerotomy in NanophthalmosAmerican Journal of Ophthalmology, 1990
- Acetazolamide Blood Concentrations are Excessive in the Elderly: Propensity for Acidosis and Relationship to Renal FunctionThe Journal of Clinical Pharmacology, 1989
- Blood Dyscrasias and Carbonic Anhydrase InhibitorsOphthalmology, 1988
- Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function.BMJ, 1984
- NanophthalmosOphthalmology, 1982
- Argon Laser Treatment for Medically Unresponsive Attacks of Angle-Closure GlaucomaAmerican Journal of Ophthalmology, 1982
- Adverse Effects After Glycerol Orally and Mannitol ParenterallyAmerican Journal of Ophthalmology, 1966